Association of CRS and ICANS with incidence of adverse bleeding and thrombosis events
| . | Total (N = 127) . | Bleeding . | P . | Thrombosis . | P . | ||
|---|---|---|---|---|---|---|---|
| Yes (n = 12) . | No (n = 115) . | Yes (n = 8) . | No (n = 119) . | ||||
| CRS maximum grade n, (%) | .26 | .18 | |||||
| Grade 0-2 | 124 (97.6) | 11 (91.7) | 113 (98.3) | — | 7 (87.5) | 117 (98.3) | — |
| Grade 3-4 | 3 (2.4) | 1 (8.3) | 2 (1.7) | — | 1 (12.5) | 2 (1.7) | — |
| ICANS maximum grade n, (%) | .01 | .04 | |||||
| Grade 0-2 | 104 (81.9) | 6 (50) | 98 (85.2) | — | 4 (50) | 100 (84) | — |
| Grade 3-4 | 23 (18.1) | 6 (50) | 17 (14.8) | — | 4 (50) | 19 (16) | — |
| . | Total (N = 127) . | Bleeding . | P . | Thrombosis . | P . | ||
|---|---|---|---|---|---|---|---|
| Yes (n = 12) . | No (n = 115) . | Yes (n = 8) . | No (n = 119) . | ||||
| CRS maximum grade n, (%) | .26 | .18 | |||||
| Grade 0-2 | 124 (97.6) | 11 (91.7) | 113 (98.3) | — | 7 (87.5) | 117 (98.3) | — |
| Grade 3-4 | 3 (2.4) | 1 (8.3) | 2 (1.7) | — | 1 (12.5) | 2 (1.7) | — |
| ICANS maximum grade n, (%) | .01 | .04 | |||||
| Grade 0-2 | 104 (81.9) | 6 (50) | 98 (85.2) | — | 4 (50) | 100 (84) | — |
| Grade 3-4 | 23 (18.1) | 6 (50) | 17 (14.8) | — | 4 (50) | 19 (16) | — |